CZ298749B6
(cs)
*
|
1996-10-18 |
2008-01-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitory serinových proteáz a farmaceutické prostředky s jejich obsahem
|
PE20011350A1
(es)
|
2000-05-19 |
2002-01-15 |
Vertex Pharma |
PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
MXPA03000626A
(es)
|
2000-07-21 |
2004-07-30 |
Schering Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de la hepatitis c.
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
DE60141608D1
(de)
*
|
2000-07-21 |
2010-04-29 |
Dendreon Corp |
Peptide als inhibitoren der ns3-serinprotease des hepatitis c virus
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
CA2422377C
(en)
|
2000-09-15 |
2010-04-13 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
EP1345922B1
(en)
|
2000-12-21 |
2006-05-31 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
EP1707571B1
(en)
|
2001-01-22 |
2011-09-28 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
JP2003007697A
(ja)
*
|
2001-06-21 |
2003-01-10 |
Hitachi Kokusai Electric Inc |
半導体装置の製造方法、基板処理方法および基板処理装置
|
JP4455056B2
(ja)
|
2001-07-11 |
2010-04-21 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
架橋二環式セリンプロテアーゼ阻害剤
|
AU2002348414B2
(en)
*
|
2001-10-24 |
2009-10-01 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine protease, particularly hepatitis C virus NS3-NS4A protease, incorporating a fused ring system
|
KR20040077767A
(ko)
|
2002-01-23 |
2004-09-06 |
쉐링 코포레이션 |
C형 간염 바이러스 감염 치료용 ns3-세린 프로테아제억제제로서의 프롤린 화합물
|
US7119072B2
(en)
|
2002-01-30 |
2006-10-10 |
Boehringer Ingelheim (Canada) Ltd. |
Macrocyclic peptides active against the hepatitis C virus
|
US6642204B2
(en)
|
2002-02-01 |
2003-11-04 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor tri-peptides
|
US7091184B2
(en)
|
2002-02-01 |
2006-08-15 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor tri-peptides
|
CN100381440C
(zh)
*
|
2002-04-11 |
2008-04-16 |
沃泰克斯药物股份有限公司 |
丝氨酸蛋白酶、特别是丙型肝炎病毒ns3-ns4蛋白酶的抑制剂
|
AU2003299519A1
(en)
*
|
2002-05-20 |
2004-05-04 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
US20050075279A1
(en)
|
2002-10-25 |
2005-04-07 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis C virus
|
AU2011203054B2
(en)
*
|
2003-04-11 |
2012-04-26 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of Serine Proteases, Particularly HCV NS3-NS4A Protease
|
TW200510391A
(en)
*
|
2003-04-11 |
2005-03-16 |
Vertex Pharma |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
ATE547412T1
(de)
*
|
2003-04-11 |
2012-03-15 |
Vertex Pharma |
Inhibitoren von serinproteasen, insbesondere hcv- ns3-ns4a-protease
|
EA009295B1
(ru)
|
2003-05-21 |
2007-12-28 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Соединения в качестве ингибиторов вируса гепатита с
|
US7109172B2
(en)
|
2003-07-18 |
2006-09-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
MY148123A
(en)
*
|
2003-09-05 |
2013-02-28 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
AR045769A1
(es)
|
2003-09-18 |
2005-11-09 |
Vertex Pharma |
Inhibidores de las serina proteasas, particularmente, la proteasa ns3-ns4a del vhc (virus hepatitis c)
|
PE20050431A1
(es)
|
2003-09-22 |
2005-07-19 |
Boehringer Ingelheim Int |
Peptidos macrociclicos activos contra el virus de la hepatitis c
|
JP4525982B2
(ja)
|
2003-09-26 |
2010-08-18 |
シェーリング コーポレイション |
C型肝炎ウイルスのns3セリンプロテアーゼの大環状インヒビター
|
AU2004282148A1
(en)
|
2003-10-10 |
2005-04-28 |
Vertex Pharmaceuticals Incoporated |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
US7491794B2
(en)
*
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
EP1944042A1
(en)
|
2003-10-27 |
2008-07-16 |
Vertex Pharmceuticals Incorporated |
Combinations for HCV treatment
|
US8187874B2
(en)
|
2003-10-27 |
2012-05-29 |
Vertex Pharmaceuticals Incorporated |
Drug discovery method
|
JP2007532479A
(ja)
|
2003-11-20 |
2007-11-15 |
シェーリング コーポレイション |
C型肝炎ウイルスns3プロテアーゼの脱ペプチド化インヒビター
|
CA2549167A1
(en)
*
|
2003-12-11 |
2005-06-30 |
Schering Corporation |
Inhibitors of hepatitis c virus ns3/ns4a serine protease
|
DE602005025855D1
(de)
|
2004-01-21 |
2011-02-24 |
Boehringer Ingelheim Pharma |
Makrocyclische peptide mit wirkung gegen das hepatitis-c-virus
|
JP5248783B2
(ja)
|
2004-01-30 |
2013-07-31 |
メディヴィル・アクチエボラーグ |
Hcvns−3セリンプロテアーゼインヒビター
|
JP2008505849A
(ja)
*
|
2004-02-04 |
2008-02-28 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
セリンプロテアーゼ、特に、hcv、ns3−ns4aプロテアーゼの阻害剤
|
US20070049593A1
(en)
|
2004-02-24 |
2007-03-01 |
Japan Tobacco Inc. |
Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
|
ATE478889T1
(de)
|
2004-02-27 |
2010-09-15 |
Schering Corp |
Neuartige verbindungen als hemmer von hepatitis c-virus ns3-serinprotease
|
US7205330B2
(en)
|
2004-02-27 |
2007-04-17 |
Schering Corporation |
Inhibitors of hepatitis C virus NS3 protease
|
CN103102389A
(zh)
|
2004-02-27 |
2013-05-15 |
默沙东公司 |
作为丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的硫化合物
|
AU2005222055A1
(en)
|
2004-02-27 |
2005-09-22 |
Schering Corporation |
Compounds as inhibitors of hepatitis C virus NS3 serine protease
|
CA2557301A1
(en)
*
|
2004-02-27 |
2005-09-15 |
Schering Corporation |
Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
|
US7635694B2
(en)
|
2004-02-27 |
2009-12-22 |
Schering Corporation |
Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
|
EP1737821B1
(en)
|
2004-02-27 |
2009-08-05 |
Schering Corporation |
3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
|
US7816326B2
(en)
|
2004-02-27 |
2010-10-19 |
Schering Corporation |
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
|
SI1725548T1
(sl)
*
|
2004-03-12 |
2015-05-29 |
Vertex Pharmaceuticals Incorporated |
Postopki in intermediati za pripravo inhibitorjev asparagin-acetal-kaspaze
|
CN1984922A
(zh)
|
2004-05-20 |
2007-06-20 |
先灵公司 |
用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的取代脯氨酸
|
UY29016A1
(es)
|
2004-07-20 |
2006-02-24 |
Boehringer Ingelheim Int |
Analogos de dipeptidos inhibidores de la hepatitis c
|
ES2366478T3
(es)
|
2004-07-20 |
2011-10-20 |
Boehringer Ingelheim International Gmbh |
Análogos peptídicos inhibidores de la hepatitis c.
|
ATE513844T1
(de)
*
|
2004-08-27 |
2011-07-15 |
Schering Corp |
Acylsulfonamidverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
|
US7659263B2
(en)
|
2004-11-12 |
2010-02-09 |
Japan Tobacco Inc. |
Thienopyrrole compound and use thereof as HCV polymerase inhibitor
|
AU2006276246B2
(en)
|
2005-07-25 |
2012-09-27 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis C virus replication
|
PL1913015T3
(pl)
|
2005-07-29 |
2014-04-30 |
Janssen R&D Ireland |
Makrocykliczne inhibitory wirusa zapalenia wątroby typu C
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
MY139923A
(en)
|
2005-07-29 |
2009-11-30 |
Tibotec Pharm Ltd |
Macrocylic inhibitors of hepatitis c virus
|
ES2401661T3
(es)
|
2005-08-02 |
2013-04-23 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de serina proteasas
|
US8399615B2
(en)
|
2005-08-19 |
2013-03-19 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates
|
ES2449268T3
(es)
*
|
2005-08-19 |
2014-03-19 |
Vertex Pharmaceuticals Inc. |
Procesos
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
UA93990C2
(ru)
|
2005-10-11 |
2011-03-25 |
Интермюн, Инк. |
Соединения и способ ингибирования репликации вируса гепатита c
|
CN103145702A
(zh)
|
2005-11-03 |
2013-06-12 |
顶点医药品公司 |
用作激酶抑制剂的氨基嘧啶
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
EP1951748B1
(en)
|
2005-11-11 |
2013-07-24 |
Vertex Pharmaceuticals, Inc. |
Hepatitis c virus variants
|
CA2643688A1
(en)
|
2006-02-27 |
2007-08-30 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
KR20080112303A
(ko)
|
2006-03-16 |
2008-12-24 |
버텍스 파마슈티칼스 인코포레이티드 |
중수소화 c형 간염 프로테아제 억제제
|
WO2007120595A2
(en)
*
|
2006-04-11 |
2007-10-25 |
Novartis Ag |
Amines for the treatment of hcv
|
DE102006059317A1
(de)
|
2006-07-04 |
2008-01-10 |
Evonik Degussa Gmbh |
Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden
|
KR20090024834A
(ko)
|
2006-07-05 |
2009-03-09 |
인터뮨, 인크. |
C형 간염 바이러스 복제의 신규 억제제
|
EP1886685A1
(en)
|
2006-08-11 |
2008-02-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
|
US8759353B2
(en)
|
2007-02-27 |
2014-06-24 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
WO2008106058A2
(en)
|
2007-02-27 |
2008-09-04 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
ES2381410T3
(es)
|
2007-05-04 |
2012-05-28 |
Vertex Pharmceuticals Incorporated |
Terapia de combinación paa el tratamiento de infecciones por VHC
|
EA200971041A1
(ru)
*
|
2007-05-10 |
2010-08-30 |
Интермьюн, Инк. |
Новые пептидные ингибиторы репликации вируса гепатита с
|
WO2009018415A1
(en)
|
2007-07-31 |
2009-02-05 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
US8492546B2
(en)
|
2007-08-30 |
2013-07-23 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
KR20110005869A
(ko)
|
2008-04-15 |
2011-01-19 |
인터뮨, 인크. |
C형 간염 바이러스 복제의 신규한 마크로사이클릭 억제제
|
AR075584A1
(es)
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
EP2435424B1
(en)
|
2009-05-29 |
2015-01-21 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
US20120276047A1
(en)
|
2009-11-25 |
2012-11-01 |
Rosenblum Stuart B |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
CA2785488A1
(en)
|
2009-12-22 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
MA34147B1
(fr)
|
2010-03-09 |
2013-04-03 |
Merck Sharp & Dohme |
Composes tricycliques fusionnes de silyle et leurs methodes d'utilisation dans le cadre du traitement de maladies virales
|
JP2013541499A
(ja)
|
2010-07-26 |
2013-11-14 |
メルク・シャープ・エンド・ドーム・コーポレイション |
置換されたビフェニレン化合物およびウイルス性疾患の治療のためのその使用方法
|
JP2013540122A
(ja)
|
2010-09-29 |
2013-10-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
|
US8729014B2
(en)
|
2010-11-01 |
2014-05-20 |
Rfs Pharma, Llc |
Specific HCV NS3 protease inhibitors
|
WO2012107589A1
(en)
|
2011-02-11 |
2012-08-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment and prevention of hcv infections
|
EP2697242B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
WO2012142085A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
WO2013033899A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
|
WO2013033901A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
|
WO2013033900A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
|
EP2755981A4
(en)
|
2011-09-14 |
2015-03-25 |
Merck Sharp & Dohme |
HETEROCYCLIC COMPOUNDS CONTAINING SILYL AND METHODS OF USING THE SAME FOR TREATING VIRAL DISEASES
|
WO2013072328A1
(en)
|
2011-11-14 |
2013-05-23 |
Sanofi |
Use of telaprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases
|
CN104039774A
(zh)
|
2012-01-12 |
2014-09-10 |
Rfs制药公司 |
Hcv ns3蛋白酶抑制剂
|
WO2014053533A1
(en)
|
2012-10-05 |
2014-04-10 |
Sanofi |
Use of substituted 3-heteroaroylamino-propionic acid derivatives as pharmaceuticals for prevention/treatment of atrial fibrillation
|
EP3063140A4
(en)
|
2013-10-30 |
2017-11-08 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
|